Literature DB >> 27638827

[Neurosarcoidosis].

W Reith1, S Roumia2, C Popp2.   

Abstract

CLINICAL/METHODICAL ISSUE: Neurosarcoidosis is a relatively rare complication of sarcoidosis that occurs in approximately 5-15 % of patients. The clinical picture is variable. Clinically, neurosarcoidosis is mostly manifested as lesions of the cranial nerves (50-70 %) and several cranial nerves are typically affected. This is the result of aseptic granulomatous basal meningitis. Intraparenchymal granulomas also occur, frequently affecting basal near-midline structures, such as the hypothalamus and pituitary glands and can lead to encephalopathy. STANDARD RADIOLOGICAL
METHODS: Diagnostics are essentially performed using magnetic resonance imaging (MRI) as it can demonstrate the thickened meninges, which have a high affinity for contrast media but the results are not specific. Particularly in the absence of systemic sarcoidosis, diagnosis can be difficult. Laboratory tests are not very sensitive and specific, which makes neurosarcoidosis a diagnostic challenge. ACHIEVEMENTS: Due to the substantial morbidity of the disease, early and consistent treatment should be initiated. This is usually carried out with corticosteroids supported by immunosuppressant drugs, such as azathioprine and methotrexate.

Entities:  

Keywords:  Corticosteroids; Magnetic resonance imaging; Neurotuberculosis; Sarcoidosis; Therapy

Mesh:

Substances:

Year:  2016        PMID: 27638827     DOI: 10.1007/s00117-016-0168-9

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  16 in total

1.  Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis.

Authors:  M W Ziegenhagen; M E Rothe; M Schlaak; J Müller-Quernheim
Journal:  Eur Respir J       Date:  2003-03       Impact factor: 16.671

Review 2.  Neurosarcoidosis: a review of its intracranial manifestation.

Authors:  D A Nowak; D C Widenka
Journal:  J Neurol       Date:  2001-05       Impact factor: 4.849

Review 3.  Imaging manifestations of neurosarcoidosis.

Authors:  J Keith Smith; Maria Gisele Matheus; Mauricio Castillo
Journal:  AJR Am J Roentgenol       Date:  2004-02       Impact factor: 3.959

Review 4.  [Sarcoidosis].

Authors:  A Prasse; J Müller-Quernheim
Journal:  Internist (Berl)       Date:  2009-05       Impact factor: 0.743

Review 5.  Sarcoidosis.

Authors:  L S Newman; C S Rose; L A Maier
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

6.  Bilateral optic neuropathy as the initial manifestation of systemic sarcoidosis.

Authors:  B M DeBroff; S P Donahue
Journal:  Am J Ophthalmol       Date:  1993-07-15       Impact factor: 5.258

Review 7.  Infections associated with tumor necrosis factor-alpha antagonists.

Authors:  David J Rychly; Joseph T DiPiro
Journal:  Pharmacotherapy       Date:  2005-09       Impact factor: 4.705

Review 8.  Pathogenesis, diagnosis, treatment, and outcome aspects of cerebral tuberculosis.

Authors:  Muralidhar K Katti
Journal:  Med Sci Monit       Date:  2004-08-20

Review 9.  [Tumors of the sellar and pineal regions].

Authors:  A Zimmer; W Reith
Journal:  Radiologe       Date:  2014-08       Impact factor: 0.635

Review 10.  Neurological complications of sarcoidosis.

Authors:  Barney J Stern
Journal:  Curr Opin Neurol       Date:  2004-06       Impact factor: 5.710

View more
  1 in total

1.  [Smouldering fire].

Authors:  S Delorme; W Reith
Journal:  Radiologe       Date:  2016-10       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.